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Abstract
The paper develops methods to construct a one-stage optimal design of dilution
experiments under the total available volume constraint typical for bio-medical ap-
plications. We consider various design criteria based on the Fisher information both
is Bayesian and non-Bayasian settings and show that the optimal design is typically
one-atomic meaning that all the dilutions should be of the same size. The main tool is
variational analysis of functions of a measure and the corresponding steepest descent
type numerical methods. Our approach is generic in the sense that it allows for inclu-
sion of additional constraints and cost components, like the cost of materials and of
the experiment itself.
Keywords: Dilution experiment, optimal design of experiments,
Fisher information criteria, gradient methods, design measure, vari-
ational analysis on measures, stem cells counting.
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1 Introduction
The paper studies a wide class of statistical experiments with the total volume
constraint arising, in particular, in stem cells research, a very active area of
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experimental biology. Stem cells are the cells produced during early stages
of embryonic development and they are having capacity to turn into various
types of tissue cells. This potentially opens new ways to cure many diseases
and explains the huge importance of the stem cells research, see, e. g., Mayhall
et al. (2004) and the references therein. We aim to characterise an optimal
design of dilution-type experiments under the contraint of the available solution
which is typical for experiments involving counting stem cells. Specifically, this
study originates in studies of Hematopoietic or blood stem cells (HSCs) which
are the stem cells giving rise to all red and white blood cells and platelets.
HSCs develop in a mammal’s embryo in early days from cells. There is not
much known on the biological mechanism which triggers a cell to develop into
an HSC and there is no direct way so far to observe such cells, called pre-HSCs,
which soon to become HSCs. Pre-HSCs are mostly produced in aorta-gonad-
mesonephros (AGM) region of the embryonic mesoderm and also in the yolk sac,
then colonise the liver. A challenging problem is how to detect the pre-HSCs
and how many of them are present at a different embryo ages.
In order to estimate the number of pre-HSCs present in a given region,
experiments on laboratory mice have been conducted which use the following
signature property of stem cells. A mature HSC is capable to cure a mouse which
receives a controlled dose of radiation if injected in its blood. A mouse recovers
(repopulates), if and only if, it has received at least one HSC in the injected
dose1. Thus the number of pre-HSCs can be estimated by the so-called limiting
dilution method : controlled dozes of a substrate containing samples from the
AGM are injected into irradiated mice and then the number of repopulated
mice infers on the number of HSCs which developed from the initially present
pre-HSCs.
The dilution method has been in the arsenal of biologists for almost a cen-
tury, at least since McCrady used it for quantitative determination of Bacillus
coli in water in 1915, McCrady (1915). Since then many studies used it to esti-
mate the number of objects of interest in a medium without their direct count,
Fisher (1922), Cochran (1950), Ridout (1995), to name a few.
So far, several studies have produced estimates for the number of pre-HSCs
in AGM by using the dilution method which varies between just a few to, per-
haps, as many as 200, see, e. g., Kumaravelu et al. (2002), Gekas et al. (2005),
Ottersbach and Dzierzak (2005) Bonnefoix and Callanan (2010) and Medvinsky
et al. (2011). Most of the reports tend to focus on the modelling of exper-
imental data and on the estimation methods. However, there has been little
discussions on how to design the experiment to capture the most informative
sample. Indeed, the experiment would be spoilt, if all the mice repopulate or
if all do not. The aim of this paper is to find an optimal design of the dilution
experiment to estimate the mean number of pre-HSCs. What distinguishes the
experiments we are dealing with in this paper from other dilution experiments
extensively covered in statistical literature are the following two features. First,
1This assumption is rather questionable, so the biologists cautiously speak of one repopu-
lation unit for this unknown minimal number of HSCs sufficient to cure an irradiated mouse.
In this study we basically loosely speak of one HSC as of one repopulation unit.
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it is the volume contraint imposed by the limited size of available substrate
from AGMs. Second, a significant time delay between the dose injection and
the result of its action prevents from using multi-stage designs when the further
stages of experiments are based on the outcomes of the previous one(s). To ad-
dress these specific issues, we employ recently developed methods of constrained
optimisation of functionals of measures and the corresponding steepest descent
type algorithms for computations. It should be stressed that our methodology
is generic in the sense that it can be applied to other dilution experiments and
not only in the stem cells research. Moreover, additional contraints can be in-
corporated into the model which would allow, for instance, to take into account
the cost of mice or other materials used in the experiment.
This study is organised in the following way. Section 2 introduces the dilu-
tion experiment we are dealing with, description of the corresponding statistical
model followed by its assumptions, and at the end the optimality criterion func-
tions. Section 3 lays out the theoretical basis for the optimisation methods we
are using given that the goal functions are represented as functions of a measure.
Consecutive sections provide the optimal design of the dilution experiments un-
der various conditions and various goal functions: in non-Bayesian setting in
Section 4.1, then under Uniform and Gamma Bayesian priors in Section 4.2,
and finally in Section 4.3 we represent an optimal design that integrates cost
to the criterion functions. We conclude by discussion of our findings and their
extensions in Section 5.
2 Dilution experiment, statistical model and op-
timality criteria
Description of experiment The dilution experiment on estimation of the
number of HSCs we address here involved the AGM region of an 11 days old
mouse embryo. More exactly, in order to make a study more representable
and not depending on features of a particular embryo, an engineered AGM
is made from several such embryos. A substrate of volume V is then made
from this engineered AGM and the content is thoroughly mixed. Next, n doses
containing proportions x1, . . . , xn of the whole V are extracted from all or part
of the substrate and left for a few days so that pre-HSCs in these doses, if any,
mature into HSCs. Finally, these n doses2 are injected into n irradiated mice
(the number n of mice was 30 in this experiment) so that each mouse receives its
own dose and the mice are put to rest for a few weeks for the doses to take effect.
After this, the number of repopulated mice, which are the ones having received
a doze with at least one pre-HSC, is counted and the inference is drawn on the
total number of pre-HSCs initially present in the AGM. The main question to
address when designing such an experiment is doses of which volumes should
be used for available number of mice in order to get best possible quality of
2These are further diluted to a standard volume, but this, obviously, does not change the
number of HSCs present before the dilution.
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the statistical estimator? Different criteria could be considered to quantify the
quality of the estimator. We will consider below most common ones based on
the Fisher information.
Statistical model Given the description of the experiment above, the follow-
ing assumptions can be made.
• Spatial homogeneity : pre-HSCs were distributed uniformly throughout the
substrate when the doses were taken. Thus there is no tendency for pairs
or groups of pre-HSCs either to cluster or to reject one another. This is
implied by the fact that the substrate was thoroughly mixed just before
the doses are taken.
• Orderliness: the probability that there are more than one pre-HSCs in a
small volume dv of substrate has order o(dv). This is a natural assumption
given that an 11 days old AGM contains about 300 thousand cells and only
no more than 200 of these are pre-HSCs.
• Independence: each cell in substrate has the same (small) probability to
turn into a pre-HSC independently of the other cells.
• Only a pre-HSC can develop into a mature HSC. So that a dose contains
at least one HSC at the time of injection to a mouse if and only if there
was a pre-HSC present in the dose at the time of its extraction from the
whole substrate.
• Finally, each dose when injected into an irradiated mouse is certain to
exhibit a positive result (repopulated mouse), whenever the dose contains
at least one HSC.
The first three assumptions above suggest that the locations of pre-HSCs in
the substrate V are given by a homogeneous Poisson point process. This follows
from the Poisson limit theorem for thinned point processes, see, e. g., Daley
and Vere-Jones (2008, Sec. 11.3). Indeed, in every subset of the substrate of a
positive volume x, the number of cells turned into pre-HSCs is well approximated
by the Poisson distribution with the parameter proportional to the mean number
of pre-HSCs in the substrate which is λx for some parameter λ > 0. Because
of the independence assumption, these numbers are independent for disjoint
subsets. Changing the units if necessary, we assume from now on that the
volume of the whole substrate is 1. The parameter λ is then the unknown
density of the Poisson point process which is also the mean number of pre-HSCs
in the substrate. Thus we operate with a measurable space carrying point
configurations inside a set V ⊂ R3 of volume 1 (the space of finite counting
measures ω on V with the minimal σ-algebra making the mappings ω 7→ ω(B)
measurable for all Borel B ⊆ V ) supplied with probability distribution Pλ so
that ω under Pλ is a homogeneous Poisson point process with density λ.
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The doses taken can now be associated with disjoint subsets V1, . . . , Vn of
V with volumes xi > 0, i = 1, . . . , n. The corresponding numbers of pre-
HSCs ω(Vi), i = 1, . . . , n in the doses are then independent Poisson distributed
random variables with parameters λxi while the total number of pre-HSCs ω(V )
is Poisson distributed with parameter λ.
In the simplest case all the doses have the same volume 0 < x ≤ 1/n. The
probability that a doze is sterile, i.e. it does not contain a pre-HSC, is then
p = P{ω(Vi) = 0} = e−λx. (1)
Thus the total number of non-repopulated mice follows Binomial distribution
with parameters n, p and the maximum likelihood estimate for the average num-
ber of HSC λ is given by
λˆ = − log pˆ
x
, (2)
where pˆ is the proportion of non-repopulated mice provided it is not 0. However,
the doses need not be necessarily all equal for an optimal design.
Let χi (i = 1, ..., n) be an indicator that a mouse, which received the ith dose
of volume xi, has not repopulated. Thus, χi is a Bernoulli random variable
χi|λ ∼ Bern(e−λxi) (3)
with the parameter equal to the probability of the ith dose to be sterile.
Hence, the log-likelihood function for the sequence χ = (χ1, ..., χn) of non-
repopulated and repopulated mice is given by
`(χ | λ,x) = −
n∑
i=1
χiλxi +
n∑
i=1
(1− χi) log(1− e−λxi), (4)
where x = (x1, ..., xn). Maximisation of this expression over λ for an observed
sample χ provides a maximum likelihood estimator (MLE) of λ for a given
design x. Our goal here is to determine the optimal design in terms of the doses
{xi}, according to a suitably chosen optimality criterion, which we describe
next.
Optimality criterion functions Recall that for a statistical model which
depends on a one-dimensional parameter λ, the Fisher information is defined
as
I(x;λ) = −Eλ
[
∂2`(χ|λ,x)
∂λ2
]
. (5)
The expectation Eλ is taken here w.r.t the random vector χ.
Derived from (4), we have in our case
I(x;λ) =
n∑
i=1
e−λxi
1− e−λxi x
2
i . (6)
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The Fisher information measures the amount of information that an observable
sample carries about the unknown parameter, which the likelihood function
depends upon. On the other hand, it is the inverse of MLE’s variance, see,
e. g., Everitt and Skrondal (2010). Thus, maximising the information cor-
responds to minimising the variance of the MLE. Therefore, maximising the
Fisher information (6) over x under constraint
∑n
i=1 xi ≤ 1 is a useful design
criterion.
It is typical in statistical experiment planning to describe design in term of
a probabilistic design measure. Typically, the design measure is atomic, so it
has a form
∑
j qjδxj , where δx is the unit mass measure concentrated on a point
{x}. The design measure reflects the (asymptotic when n→∞) frequency qj of
occurrence of the value xj in the design, see, e. g., Atkinson and Donev (1992).
By this reason, we will also describe the doses by a measure µ(dx) living on
(0, 1], albeit not renormalised to have mass 1. Namely, µ =
∑
jmjδxj means
the design when a dose of volume xj is repeated mj times. Since it is senseless
for an experiment involving estimation of λ to give a mouse zero-doze of the
substrate, we exclude the point 0 from the design space. Obviously, we have that
the total mass constraint
∑k
j=1mj =
∫
µ(dx) = n and that we cannot extract
more doses than the total volume of the substrate:
∑k
j=1mjxj =
∫
xµ(dx) ≤ 1.
All integrals here and below are taken over (0, 1], unless specified differently.
Now the basic optimisation problem for the design of our experiment is
G1(µ;λ) = I(µ;λ) =
∫
e−λx
1− e−λxx
2 µ(dx)→ sup (7)
over measures µ with support suppµ ⊆ [0, 1] satisfying
µ({0}) = 0;
µ((0, 1]) = n; (8)∫
xµ(dx) ≤ 1. (9)
A design measure describes asymptotic frequencies, so qjn = mj for a given
finite n may not be all integers. In this case it is reasonable to consider the
nearest measure with all mj ∈ Z+ as an approximation to the optimal solution.
Or, if necessary, a choice of the optimal measure among such measures can be
done by evaluation of the goal function at just a few closest approximations of
this kind to the optimal design measure.
Bayesian setting Sometimes, there is an additional information available on
the plausible values of the parameter λ which is given in a form of a prior
distribution Q(dλ), see, e. g., Marin and Robert (2007, Sec. 2.2.2). In this case
the optimality criterion involves taking the expectation of the goal functions
w.r.t the distribution Q.
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For a single parameter, the following criterion functions are typically used to
find an optimal design, see, e.g., Atkinson and Donev (1992) or Ridout (1995):
G2(µ) = EQ I(µ;λ) (10)
G3(µ) = EQ log I(µ;λ) (11)
G4(µ) = −EQ
(
I(µ;λ)
)−1
(12)
Criterion function G2 and G3 maximize, under the same constraints (8) and
(9), the expectation of the Fisher information and of its logarithm, respectively,
as used in e.g., in Zacks (1977) and Chaloner and Larntz (1989). The crite-
rion function G4 minimises the expected asymptotic variance of the maximum
likelihood estimator.
Next section will describe a general framework of optimisation of functionals
of measures and the recently developed techniques for solving such optimisation
problems. Apart from optimal design of statistical experiments Pukelsheim
(1983), Atkinson and Donev (1992), these are frequent in different subjects,
like spline approximation of curves and geometrical bodies where the measure
describes the positions of spline points Schneider (1988), maximisation the area
covered by random geometric objects with the distribution determined by a
measure Hall (1988), stochastic search, where a measure determines the search
strategy Wynn and Zhigljavsky (1994), Zhigljavsky (1991).
3 Optimisation of functionals of measures
In this section we summarise necessary information about measures and varia-
tional analysis on them. Further details on measure theory can be found, e. g.
in Dunford and Schwartz (2009) or Hille and Philip (1957).
Let X be a locally compact separable topological space with the Borel σ-
algebra B of its subsets. Let M (M+) denote the set of signed (respectively,
non-negative) finite measures on B, i. e. countably additive functions from B
to R (R+, respectively). M becomes a linear space if the sum of measures
and multiplication by a number is defined by (η + ν)(B) = η(B) + ν(B) and
(tη)(B) = tη(B) for any t ∈ R and η, ν ∈ M. M+ is a cone in M since
µ+ ν ∈ M+ and tµ ∈ M+ whenever µ, ν ∈ M+ and t ≥ 0. The support suppµ
of a positive measure µ, is defined as the complement to the union of all open
sets of zero µ-measure. Measures are orthogonal if their supports are disjoint.
Any signed measure η can be represented as the difference η+ − η− of two
orthogonal non-negative measures η+, η− ∈ M+ (the Jordan decomposition).
The set M becomes a Banach space if supplied with the total variation norm
‖η‖ = η+(X) + η−(X).
Optimisation of functions defined on a Banach space, which are commonly
called functionals, relies on the notions of differentiability. In our case a func-
tional f : M 7→ R is called strongly or Fre´chet differentiable at ν ∈M if
f(ν + η)− f(ν) = Df(ν)[η] + o(‖η‖) as ‖η‖ ↓ 0, (13)
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where Df(ν) is a bounded linear continuous functional on M called the differ-
ential.
When a function is strongly differentiable at ν then there also exists a weak
(or directional or Gateaux ) derivative, i. e.
lim
t↓0
t−1[f(ν + tη)− f(ν)] = Df(ν)[η] (14)
for any ‘direction’ η ∈M.
The differential Df(ν) often has an integral form:
Df(ν)[η] =
∫
g(x; ν) η(dx)
for some function g( • ; ν) : X 7→ R which is then called the gradient function to
f at ν. Not all linear functionals are integrals, unless the space X is a finite set
in which case M can just be identified with an Euclidean space. In most applica-
tions, however, including the experimental design, differentiable functionals do
possess a gradient function, so this assumption is not too restrictive in practice.
In this study we are interested in optimisation of functionals of positive
measures. A general constrained optimisation problem can be written as follows:
f(µ) −→ inf, µ ∈ A, (15)
where A ⊆ M+ is a set of measures describing the constraints. If f is strongly
differentiable then the first order necessary optimality condition states that if
µ∗ provides a local minimum in the problem (15) then
Df(µ∗)[η] ≥ 0 for all η ∈ TA(µ∗), (16)
where
TA(µ) = lim inf
t↓0
A− µ
t
(17)
is the tangent cone to A at µ. Here the ‘+’ (respectively ‘−’) operation on
sets indicates all pairwise sums of (respectively difference between) the points
from the corresponding sets. The tangent cone is the closure of all admissible
directions η ∈M at µ meaning that µ+tη ∈ A for all sufficiently small t > 0, see,
e. g., Cominetti (1990). In other words, derivative in all admissible directions
should be non-negative at a point of local minimum. For any A of interest, one
needs to characterise the tangent cone TA(µ).
General optimisation theory for functionals of measures has been developed
in a series of papers Molchanov and Zuyev (2000a), Molchanov and Zuyev
(2000b) and Molchanov and Zuyev (2004). For us here an optimisation with
finite number of equality and inequality constraints is relevant.
Consider the following optimisation problem:
f(µ)→ inf, µ ∈M+ subject to (18){
Hi(m) = 0 i = 1, ..., k, k ≤ d
Hj(m) ≤ 0 j = k + 1, ..., d.
(19)
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where f : M+ 7→ R and H = (H1, . . . ,Hd) : M+ 7→ Rd are strongly differen-
tiable functions. Alternatively, the constraints (19) can be written in the form
H(µ) ∈ C, where C ⊂ Rd is the cone {y ∈ Rd : y1 = · · · = yk = 0, yk+1 ≤
0, . . . , yd ≤ 0}.
Definition 1 (Robinson (1976)). A measure µ is called regular for optimisation
problem (18) if the origin 0 of Rd belongs to the interior of the set
H(µ)− C +DH(µ)[M+ − µ] ⊆ Rd. (20)
Robinson’s regularity condition which as shown in Zowe and Kurcyusz (1979),
guarantees the existence and boundedness of the KuhnTucker vector appearing
in the next theorem. See also Maurer and Zowe (1979) for the discussion of
different forms of regularity condition.
The following theorem gives the first-order necessary conditions for a mini-
mum in the problem (18).
Theorem 1. Molchanov and Zuyev (2000a, Th. 4.1). Let µ∗ be a regular local
minimum of f over M+, subject to (19). Assume that f and H are Fre´chet
differentiable at µ∗, and there exist the corresponding gradient functions g(x, µ∗)
and hi(x, µ
∗), i = 1, ..., d. Then there exists KuhnTucker vector (u1, . . . , ud) ∈
Rd such that uj ≤ 0 (resp. uj = 0) for those j ∈ {k + 1, ..., d} satisfying
Hj(µ
∗) = 0 (resp. Hj(µ∗) < 0), such that
g(x, µ∗)
{
=
∑d
i=1 uihi(x, µ
∗) for µ∗-almost all x,
≥∑di=1 uihi(x, µ∗) for all x ∈ X. (21)
One can show that in the case of finitely many constraints (19) satisfy-
ing (21), the regularity condition (20) becomes the so-called Mangasarian–
Fromowitz constraints qualification (see Cominetti (1990, p. 274)), that is the
linear independence of the gradient functions h1( • , µ
∗), . . . , hk( • , µ∗) and the
existence of a measure η ∈M such that∫
hi(x, µ
∗) η(dx) = 0 for all i = 1, ..., k; (22)∫
hj(x, µ
∗) η(dx) < 0 for all j ∈ {k + 1, ..., d}
verifying Hj(µ
∗) = 0. (23)
Without the inequality constraints, condition (23), trivially holds for η being
the zero measure.
The design problems we consider naturally fall in the above described general
framework of optimisation of functionals defined on finite measures. Theorem 1
provides the necessary conditions for optimality of a design. Moreover, it allows
one to easily incorporate into the model other constraints on the optimal design
measure, if needed. Constraints (8) and (9) correspond to linear functionals
H1(µ) =
∫
µ(dx)−n and H2(µ) =
∫
xµ(dx)−1 with the corresponding gradient
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functions h1(x;µ) ≡ 1 and h2(x;µ) = x. These constraints are regular for any
µ since (22) and (23) are satisfied, for instance, for a measure η = δ0 − δ1. We
therefore have the following important corollary of Theorem 1 which we use in
the next section. Note that we mostly maximise the goal function so that the
inequalities in (21) change to opposite.
Theorem 2. Let µ∗ be a local maximum of a strongly differentiable function
f : M+ 7→ R possessing a gradient function g(x;µ∗), subject to contraints (8)
and (9). Then, there exist constants u1 and u2, where u2 ≥ 0 if
∫
xµ∗(dx) = 1
and u2 = 0 if
∫
xµ∗(dx) < 1, such that
g(x, µ∗)
{
= u1 + u2x µ
∗-almost everywhere,
≤ u1 + u2x for all x ∈ X.
(24)
4 Construction of optimal design
In this section we apply the necessary condition for extremum of a functional
of measures to find optimal designs for a range of goal functions and most
common prior distributions in the Bayesian settings. First we assume that
the parameter λ, the mean number of HSCs in the substrate, is known from
previous experiments, and obtain the optimal design, in terms of maximisation
of the Fisher information, for each λ.
4.1 Optimal design for a fixed average number of HSCs
Here we are dealing with optimisation problem (7) under constraints (8) and
(9). The goal function is a linear function of µ, so that its differential is the
function itself with the gradient function
g1(x;λ) =
e−λx
1− e−λxx
2, (25)
independent of µ. Note that g1(x;λ) = λ
−2r(λx), where
r(y) =
e−y
1− e−y y
2. (26)
The graph of r is shown on Figure 1. It attains its unique maximum at point
ymax ≈ 1.59362 and it is strictly concave on [0, ymax].
The gradient function g1 is just the function r scaled along both axes, and
it attains its maximum at the point ymax/λ. It follows from Theorem 2, that if
µ∗ is a measure at which G1 attains its maximum, then g1(x;λ) ≤ u1 + u2x for
all x ∈ [0, 1] with u2 ≥ 0. Moreover, g1(x;λ) = u1 + u2x for x ∈ suppµ∗. But
this is only possible if u1 + u2x is a tangent line to g1 at some x
∗ ∈ [0, ymax/λ]
and hence the support of optimal µ∗ consists of only this point x∗. Using (8)
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and substituting µ = nδx into (7) and (9), we come to the optimisation problem
of one variable:
r(λx)→ sup over x ∈ [0, 1/n],
so that x∗ = 1/n for λ ≤ ymaxn and x∗ = ymax/λ, otherwise. Thus we have
proved the following theorem.
Theorem 3. The optimal design for the problem (7) under constraints (8) and
(9) consists in n equal doses of volume 1/n for λ ≤ ymaxn and of volume ymax/λ
for λ > ymaxn, where ymax ≈ 1.59362 is the maximum point of the function r
(26).
This indicates that for those λ > 1.59362n we need to sample a proportion
of the substrate 1.59362n/λ, and for those λ ≤ 1.59362n we have to take all
the substrate. Therefore, if a good prior point estimate of λ is available, a near
optimal doses of volume x∗ can be selected, see Figure 1.
4.2 Optimal design with prior distribution on λ
Typically researchers already have an idea on what are the most likely values
of λ. This can be suggested by previous experiments or by analogy with other
similar cases and it is given in the form of a prior distribution Q(dλ). The
optimal experimental design now becomes dependent not only on the choice of
a criterion, but also on the parameters of Q. Formally, the locations of pre-HSCs
in the substrate now conform to a Cox (or mixed Poisson) point processes with
parameter measure Q.
In this section we carry out optimisation of the three goal functions intro-
duced above in (10)–(12) for the most common prior distributions: Uniform and
Gamma.
Uniform prior distribution. The Uniform prior distribution is appropriate
when there is no knowledge on the mean number λ of pre-HSCs in substrate
apart from its range. Certainly, λ should be greater than 1 since pre−HSCs do
develop in the AGM. So, it is reasonable to assume that λ ∼ Unif(1, u), where
u > 1 is a known upper bound. It was already mentioned that the number of
pre-HSCs hardly exceeds 200, so one can set u = 200, or, keeping in mind the
variance of the Poisson distribution, u = 170, for instance.
The goal function (10) now becomes
G2(µ;u) =
1
u− 1
u∫
1
∫
(0,1]
e−λx
1− e−λxx
2µ(dx) dλ.
By Fubini’s theorem we can change the order of integrals above to arrive at
G2(µ;u) =
1
u− 1
∫
(0,1]
x log
1− e−ux
1− e−x µ(dx). (27)
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Thus G2(µ;u) is a linear functional of µ with the gradient function
g2(x;u) =
x
u− 1 log
1− e−ux
1− e−x . (28)
This function varies very little for all practically interesting values of u ≥ 5
with the maximum value attained around 0.69—0.7, see Figure 2. Reasoning
the same way as we did in Section 4.1, we can conclude that for any u ≥ 2
the optimal design is attained on one atom design measure concentrated on the
point 1/n (cf. Plot (c) in Figure 1). So the whole volume of the substrate should
be divided into n equal doses for this goal function.
Consider now optimisation criterion (11) which now takes the form
G3(µ;u) =
1
u− 1
u∫
1
log
( ∫
(0,1]
e−λx
1− e−λxx
2µ(dx)
)
dλ. (29)
This goal function is not linear, but still Fre´chet differentiable with the gradient
function given by
g3(x, µ;u) =
1
u− 1
u∫
1
I−1(µ;λ)
e−λx
1− e−λxx
2 dλ, (30)
where
I(µ;λ) =
∫
e−λx
1− e−λxx
2 µ(dx) (31)
is the Fisher information written in terms of a design measure. Since the gra-
dient now depends on µ, numeric methods have to be employed to find the
optimal design for a given value of the upper bound u and the number of mice
n. This was done by means of R-library medea which finds an optimal solution
to a measure optimisation problem under linear constrains of equality type, see
Molchanov and Zuyev (2002). Since medea does not yet allow for inequality
constraints, to deal with (9), the procedure looks for an optimum measure for
a given value b of the integral
∫
xµ(dx) and then optimises over b ≤ 1. The
R-code is freely available from one of the authors’ web-page3.
Numeric experiments conducted for various values of u show that the ob-
tained optimal solution is always one-atom as in the previous cases. Typically,
the numeric solution gives two atoms at the neighbouring points of the discre-
tised space [0, 1] for x which indicates a single atom is situated in between these
grid points, see Figure 3. Although we cannot formally prove that the optimum
design is one-atom, such designs (i. e. equal doses) are certainly of an interest.
One-atom measures under constraint (8) have a form µ = nδx for some
x ∈ (0, 1/n]. Making use of (26), we come to a one variable optimisation
3http://www.math.chalmers.se/˜ sergei
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problem: maximise
G3(nδx) = log n− 2 EQ log λ+ EQ log r(λx) (32)
subject to x∗ ≤ 1/n and Q is Unif[1, u]. Only the last term depends on x, so
the equivalent problem is to maximise
G˜3(x;u) = EQ log r(λx) =
1
u− 1
u∫
1
log r(λx) dλ.
As u grows, the maximum xmax of this function, which can easily be computed
numerically, approaches 0, see the right plot on Figure 4. So when xmax ≥ 1/n,
the constrained maximum is attained at the point 1/n. Otherwise, for large
u, xmax < 1/n and the solution is to take n doses of volume xmax. This is
exemplified at Figure 4 for n = 30: the optimal dose is given by
x∗ =
{
1
n u ≤ u∗;
xmax u > u
∗.
(33)
where u∗ ≈ 90.66. This indicates that for those u ≤ u∗ one needs to take all
the substrate to make n equal doses, and the volume nxmax otherwise.
Finally, consider objective function G4 given by (12) which corresponds to
the expected asymptotic variance of the maximum likelihood estimator. In the
case of a Uniform prior λ ∼ Unif(1, u),
G4(µ;u) = − 1
u− 1
u∫
1
I−1(µ;λ) dλ, (34)
where I(µ;λ) is given by (31). Again, G4 is Fre´chet differentiable with the
gradient function
g4(x, µ;u) =
1
u− 1
u∫
1
I−2(µ;λ)
e−λx
1− e−λxx
2 dλ (35)
and a numeric procedure should be used to find the optimal measure for any
given values of u and n. Similarly to the case of objective function G3 above,
numeric experiments show that the optimal measure is one atomic, although we
cannot show this rigorously. In the class of one-atomic measures µ = nδx the
goal function simplifies to
G4(nδx;u) = −e
ux − ex − x(u− 1)
nx3(u− 1) (36)
Similarly to G3 above, the point of maximum xmax of this function approaches
0 when u grows, see the right plot on Figure 5. So that when u is such that
xmax > 1/n the optimal dose is 1/n (the whole substrate is used), otherwise the
optimal dose is xmax. For example, for n = 30 mice, the optimal dose is also
given by (33) but with u∗ ≈ 64.47 this time.
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Gamma prior distribution. Gamma prior distribution arises naturally as
a posterior distribution for the Poisson parameter λ which has a Uniform prior
distribution. Since the probability of having k pre-HSCs in the substrate is
P{ω(V ) = k} = EQ P{ω(V ) = k | λ} = 1
u− 1
u∫
1
λke−λ
k!
dλ, (37)
The posterior p.d.f. for λ is then
fλ(x | ω(V ) = k) = x
ke−x∫ u
1
λke−λdλ
∝ xke−x, (38)
which is close to Γ(k + 1, 1) distribution for large u. So once an estimate for
the total number of pre-HSCs k is available, the Gamma prior would be a
reasonable for λ in the subsequent experiment. Moreover, posterior distribution
for a Gamma prior Γ(α, 1) given k pre-HSCs will be Γ(α + k, 2) and so on.
So generally, λ ∼ Γ(α, β) with rate parameter β ∈ N could be a reasonable
assumption.
Under this assumption, Criterion (10) becomes
G2(µ;α, β) =
∞∫
0
∫
(0,1]
fα,β(λ)
e−λx
1− e−λxx
2 µ(dx)dλ , (39)
where
fα,β(λ) =
βα
Γ(α)
λα−1e−βλ. (40)
So G2 is a linear functional with the gradient function
g2(x, µ;α, β) =
∞∫
0
e−λx
1− e−λxx
2fα,β(λ)dλ =
∞∫
0
r(λx)λ−2fα,β(λ)dλ
=
β2
(α− 1)(α− 2)
∞∫
0
r(λx)fα−2,β(λ)dλ
=
β2
(α− 1)(α− 2)
∞∫
0
r(λ)fα−2,β/x(λ)dλ. (41)
Thus the situation here is similar to the case of the Uniform distribution: de-
pending on whether the maximum of this function is below or above 1/n one
needs to take equal doses of volumes xmax the point where g2 attains its maxi-
mum or 1/n, respectively.
Consider as an example the first-iteration case when β = 1. The gradient
function and the point of maximum are shown in Figure 6. The optimal design
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is given by
x∗ =
{
1
n α ≤ α∗;
xmax α > α
∗.
(42)
where α∗ ≈ 49.68.
Under Gamma prior (40), criterion function (11) takes the following form:
G3(µ;α, β) =
∞∫
0
fα,β(λ) log I(µ;λ)dλ, (43)
where I(µ;λ) is given by (31). Note that G3 is not a linear functional of a
measure, however it is Fre´chet differentiable with the gradient function
g3(x, µ;α, β) =
∞∫
0
I−1(µ;λ)
e−λx
1− e−λxx
2fα,β(λ)dλ. (44)
Thus, as before numeric methods for β = 1 and a given values of α and n should
be employed. Our experiments show that the optimum measure given by the
steepest descent algorithm still contains only one atom. So, optimising (43) for
one atomic measures nδx over x ∈ (0, 1/n] leads to the design given by (42),
with α∗ ≈ 47.70. Figure 7 shows G3(nδx;α) and the optimal equal doses for
different values of α.
Finally, consider G4 in (12) with Gamma prior distribution on λ:
G4(µ;α, β) = −
∞∫
0
I−1(µ;λ)fα,β(λ)dλ, (45)
which is Fre´chet differentiable with the gradient function
g4(x, µ;α, β) =
∞∫
0
I−2(µ;λ)
e−λx
1− e−λxx
2fα,β(λ)dλ. (46)
Here also, our numeric experiments for β = 1 and any given values of α and n,
show that the optimal measure contains a single atom. Thus, in the class of one
atomic measures, (45) simplifies to
G4(nδx;α) = − 1
nx2
∞∫
0
1− e−λx
e−λx
fα(λ)dλ. (47)
which leads to the one-atom optimal design (42) with α∗ ≈ 45.74, see Figure 8.
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4.3 Optimal design with additional costs
The measure optimisation formalism we used above allows for seamless inclusion
of different costs associated with the experiment either as additional terms in
the goal function or as additional contraints. This can be done in both non-
Bayesian and Bayesian settings. Typical loss incured in the above described
experiment are the non-repopulated laboratory mice which are quite expensive.
Added to this, the cost of all the experiment when all mice die or all mice survive
so if it does not yield meaningful results. In this section we demonstrate how
these costs affect the optimal experimental design.
Non-Bayesian setting. To take into account the cost of non-repopulated
mice, note that for a fixed λ, the indicator χi that the mouse which received
the ith dose of volume xi has not repopulated is a Bernoulli random variable
with a parameter e−λxi , see (3). Thus, the mean number of non-repopulated
mice E
∑n
i=1 χi is
T1(x;λ) =
n∑
i=1
e−λxi , (48)
which can be represented as a functional of the design measure µ as follows:
T1(µ;λ) =
∫
e−λxµ(dx). (49)
Recall that as in the previous sections, all the integrals are taken over the range
(0, 1]. To include the cost associated with a spoilt experiment, compute the
probability that all the mice do not repopulate which can be written as follows:
T21(x;λ) =
n∏
i
P{χi = 1}
=
n∏
i=1
e−λxi = e−λ
∑n
i=1 xi . (50)
Consequently, the probability that all the mice repopulate is
T20(x;λ) =
n∏
i=1
P{χi = 0} =
n∏
i=1
(1− e−λxi) = e
∑n
i=1 log(1−e−λxi ). (51)
In terms of the design measure, (50) and (51) are the following functionals:
T21(µ;λ) = e
−λ ∫ xµ(dx) (52)
T20(µ;λ) = e
∫
log(1−e−λx)µ(dx). (53)
This gives rise to the expression for the probability of a spoilt experiment due
to either all the mice repopulating or all the mice non-repopulating:
T2(µ;λ) = T21(µ;λ) + T20(µ;λ). (54)
16
We note that T1 and T2 are Fre´chet differentiable with the gradient functions
t1(x;λ) = e
−λx (55)
and
t2(x, µ;λ) = −λxT21(µ;λ) + log(1− e−λx)T20(µ;λ). (56)
Now consider maximisation of a new goal function
G˜1(µ;λ) = G1(µ;λ)− c1T1(µ;λ)− c2T2(µ;λ), (57)
where G1 is given by (7), under constraints (8) and (9). The positive constants
c1, c2 should be set by the experimentator to reflect the cost of mice and of a
spoilt experiment which should be offset against the usefulness of the results
reflected in the original goal function G1 involving the Fisher information.
The function G˜1 is strongly diferentiable with the gradient function given
by
g˜1(x, µ;λ) = g1(x;λ)− c1t1(x;λ)− c2t2(x, µ;λ), (58)
where g1 as in (25).
Figure 9 shows the optimal dose as a function of λ, for n = 30, c1 = 10
−4
and c2 = 1. Compared to the optimal design for G1 shown on Figure 1 one has
to dilute more and also to start dilution earlier at λ = 41.8 compared to 47.8 for
G1 which reflects the caution not to allow all the mice to survive as this would
mean a spoilt experiment.
Bayesian setting. Under Γ(α, 1) prior distribution for λ, the average number
of non-repopulated mice becomes
EQ T1(µ;λ) =
∫
1
(1 + x)α
µ(dx), (59)
with the gradient function
EQ t1(x;λ) =
1
(1 + x)α
. (60)
The probability of a spoilt experiment is
EQ T2(µ;λ) = EQ T21(µ;λ) + EQ T20(µ;λ) (61)
=
1
(1 +H(µ))α
+ EQ T20(µ;λ), (62)
with the corresponding gradient function
EQ t2(x, µ;λ) = − αx
(1 +H(µ))α+1
+ EQ log(1− e−λx)T20(µ;λ), (63)
where H(µ) =
∫
xµ(dx).
17
Take G4 as in (45) with β = 1 and consider a new goal function
G˜4(µ;α) = G4(µ;α)− c1 EQ T1(µ;λ)− c2 EQ T2(µ;λ). (64)
It is Fre´chet differentiable and possesses a gradient function
g˜4(x, µ;α) = g4(µ, x;α)− c1 EQ t1(x;λ)− c2 EQ t2(x, µ;λ). (65)
We are aiming to maximise G˜4 under the same constraints (8) and (9).
Again, numeric solutions are still one-atomic for different tried values of
the parameters α, c1 and c2 we tried. Figure 10 shows a typical picture for
− log |G˜4(nδx;α)| for the class of one-atomic design measures and the optimal
doses for three different values of α.
Mixture prior distribution Finally, consider the setting typical for testing
two alternative hypotheses about possible values of the mean number of pre-
HSCs. Suppose that λ can take two different values, our prior belief is that it
is rather λ1 than λ2 with probability 0 < p < 1. This gives rise to optimisation
of the following goal function
G1M (µ; p, λ1, λ2) = p G1(µ;λ1) + (1− p) G1(µ;λ2). (66)
under constraints (8) and (9).
The gradient function for (66) is
g1M (x; p, λ1, λ2) = p g1(x;λ1) + (1− p) g1(x;λ2). (67)
and numerical optimisation can be employed to find the optimal design for any
particular values of λ1, λ2 and p. For example of λ1 = 25, λ2 = 150 and p = 0.05,
Figure 11 shows a numerically obtained optimal measure which is two-atomic:
19 mice should receive equal doses of 0.019 and the rest 11 of them should
receive the same doses of 0.058.
5 Discussion
We have considered dilution experiments with volume constraints typical in
biological and medical research. An important particularity of the experiments
we consider here is that the time delay necessary for pre-HSCs to develop and
then for the injected doses to take effect in mice prevents from planing multiple
stage experiments: the estimation should necessarily be done from the first and
only stage. As we have seen, in all the considered cases of the goal functions,
the optimal design is attained on a one-point measure, meaning that all the
doses should have equal volume. This parallels the well known result about the
D-optimal design measure for a linear regression model: The Kiefer-Wolfowitz
theorem assures that such measure is atomic with the number of atoms to be
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at most the number of contraints plus one, see, e. g., Kiefer and Wolfowitz
(1960). In our case we have one volume constraint (in addition to the measure
to have a fixed total mass) so the number of atoms is at most two. Indeed, the
gradient functions we observed are convex on the interval from 0 to the point of
maximum, so the only possibility to satisfy the necessary optimality condition
given in Theorem 2, is for the optimal measure to have only one atom. However,
the example of a mixture prior distribution considered in the last section shows
that two-atom designs are indeed possible.
In practical terms, if the number of pre-HSC expected to be not very large
(a few dozens or less), the whole substrate should be used to derive the doses,
otherwise only part of it. We have characterised above what is ‘not very large’
and how much the doses should be diluted. We have fixed some of the parame-
ters here (the number of mice n = 30, β = 1), driven by practical applications
to stem cell research. For other applications and other values of these param-
eters one make use the computer codes the authors make freely available for
download.
Advantage of measure optimisation approach is that additional requirements
can be easily incorporated into the goal function or added as further constraints,
e. g. limited cost associated with non-repopulated mice and/or the cost of the
whole experiment if all mice are repopulated or all are not repopulated.
References
Atkinson, A. C. and A. N. Donev (1992). Optimum Experimental Designs.
Oxford: Clarendon Press.
Bonnefoix, T. and M. Callanan (2010). Accurate hematopoietic stem cell
frequency estimates by fitting multicell poisson models substituing to
the single-hit poisson model in limiting dilution transplantation assays.
Blood 116 (14), 2472–2475.
Chaloner, K. and K. Larntz (1989). Optimal bayesian design applied to lo-
gistic regression experiments. J. Statis. Planng Inf. 21, 191–208.
Cochran, W. G. (1950). Estimation of bacterial densities by means of the
”Most Probable Number”. Biometrics 6, 105–116.
Cominetti, R. (1990). Metric regularity, tangent sets, and second-order opti-
mality conditions. Appl. Math. Optim. 21, 265–287.
Daley, D. J. and D. Vere-Jones (2008). An Introduction to the Theory of Point
Processes. Volume II: General Theory and Structure (2nd ed.). New York:
Springer.
Dunford, N. and J. T. Schwartz (2009). Linear Operators: Part 1, General
Theory. New Jersey: John Wiley & Sons.
Everitt, B. S. and A. Skrondal (2010). The Cambridge dictionary of statistics,
4th edition. New York: Cambridge university press.
19
Fisher, R. A. (1922). On the mathemtical foundation of theoretical statistics.
Philosophical Transactions of the Royal Society of London. Series A, Con-
taining Papers of a Mathematical or Physical Character. 222, 309–368.
Gekas, C., F. Dieterlen-Lievre, S. H. Orkin, and H. K. A. Mikkola (2005).
The placenta is a niche for hematopoietic stem cells. Developmental 8,
365–375.
Hall, P. (1988). Introduction to the theory of Coverage Processes. New York:
Wiley.
Hille, E. and R. S. Philip (1957). Functional Analysis and Semigroups. New
York: American Mathematical Society.
Kiefer, J. and J. Wolfowitz (1960). The equivalence of two extremum prob-
lems. Canadian Journal of Mathematics. 12, 363–366.
Kumaravelu, R., L. Hook, A. M. Morrison, J. Ure, S. Zhao, S. Zuyev,
J. Ansell, and A. Medvinsky (2002). Quantitative developmental anatomy
of definitive haematopoietic stem cells/long-term repopulating units
(hsc/rus): role of the aorta-gonad-mesonephros (agm) region and the yolk
sac in colonisation of the mouse embryonic liver. Developmental 129, 4891–
4899.
Marin, J. and C. P. Robert (2007). Bayesian Core: A Practical Approach to
Computational Bayesian Statistics. New York: Springer.
Maurer, H. and J. Zowe (1979). First and second order necessary and suf-
ficient optimality conditions for infinite-dimensional programming prob-
lems. Math. Programming 16, 98–110.
Mayhall, E. A., N. Paffett-Lugassy, and L. I. Zon (2004). The clinical potential
of stem cells. Current Opinion in Cell Biology. 16 (6), 713–720.
McCrady, M. H. (1915). The numerical interpretation of fermentation-tube
results. The Journal of Infectious Diseases 17 (1), 183–212.
Medvinsky, A., S. Rybtsov, and S. Taoudi (2011). Embryonic origin of the
adult hematopoietic system: advances and questions. Development. 138,
1017–1031.
Molchanov, I. and S. Zuyev (2000a). Tangent sets in the space of measures:
with applications to variational calculus. J. Math. Anal. Appl. 249, 539–
552.
Molchanov, I. and S. Zuyev (2000b). Variational analysis of functionals of a
poisson process. Math. Oper. Res. 25, 485–508.
Molchanov, I. and S. Zuyev (2002). Steepest decent algorithm in a space of
measures. Statistics and Computing 12 (2), 115–123.
Molchanov, I. and S. Zuyev (2004). Optimization in space of measures and
optimal design. ESAIM 8, 12–24.
Ottersbach, K. and E. Dzierzak (2005). The murine placenta contains
hematopoietic stem cells within the vascular labyrinth region. Dev. Cell. 8,
377–387.
20
Pukelsheim, F. (1983). Optimal Design of Experiments. New York: Wiley.
Ridout, M. S. (1995). Three-stage design for seed testing experiments. Appl.
Statist. 44, 153–162.
Robinson, S. M. (1976). First order conditions for general nonlinear optimiza-
tion. SIAM J. Appl. Math. 30, 597–607.
Schneider, R. (1988). Random approximations of convex sets. J. Mi-
croscopy 151, 211–227.
Wynn, H. P. and A. A. Zhigljavsky (1994). The theory of search from a
statistical viewpoint. Test 3, 1–45.
Zacks, S. (1977). Problems and approaches in design of experiments for es-
timation and testing in non-linear models. In Multivariate Analysis 4,
209–223.
Zhigljavsky, A. A. (1991). Theory of Global Random Search. Dordrecht:
Kluwer Academic.
Zowe, J. and S. Kurcyusz (1979). Regularity and stability for the mathe-
matical programming problem in banach spaces. Appl. Math. Optim. 5,
49–62.
21
(a)
0 2 4 6 8
0.
0
0.
2
0.
4
0.
6
0.
8
(b)
0 50 100 150 200
0.
00
0.
01
0.
02
0.
03
0.
04
(c)
0.00 0.05 0.10 0.15 0.20
0.
00
00
0.
00
05
0.
00
10
0.
00
15
0.
00
20
l
(d)
0.00 0.01 0.02 0.03 0.04
0e
+0
0
2e
−0
5
4e
−0
5
6e
−0
5
8e
−0
5
l
Figure 1: Plot (a): function r, the maximum is attained at the point ymax ≈
1.59362. (b): the optimal dose volume for n = 30 mice as a function of λ:
1/30 for λ ≤ 47.8 and 1.59362/λ otherwise. The line u1 + u2x and the gradient
function g1(x;λ) satisfying conditions (24) for λ = 20 (Plot (c), the tangent
line at point 1/30) and for λ = 100 (Plot (d), the tangent line at the point of
maximum ymax/λ < 1/30).
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Figure 2: Function (u − 1)g2(x;u) for the values u = 10, 20, 200, 1000 (in the
order of increase). The last two curves are almost indistinguishable.
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Figure 3: Numeric solution obtained by medea for u = 120 (left pair of plots)
and for u = 20 (right pair) for n = 30 mice. For u = 120, the one-atom optimal
measure is 30 δx∗ , where x
∗ = 0.02522. The numeric solution is two-atomic:
29.97 δ0.025 + 0.03 δ0.026. So, the total mass of 30 was distributed between the
grid points surrounding the true atom position. Similarly, for u = 20 the one-
atom optimal measure is 30 δx∗ with x
∗ = 1/30. The numeric solution is a
two-atom measure 20.07 δ0.033 + 9.93 δ0.034.
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Figure 4: Left plot: function G˜3 for u = 50, 100 and 200. As u grows, the point
of maximum xmax approaches 0. The vertical dashed line is through the point
1/n with n = 30. Right plot: xmax as a function of u (horizontal dashed line is
through 1/n for n = 30).
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Figure 5: Left plot: function − log(|nG4(nδx;u)|) for u = 20, 50 and 100 (from
upper to lower curve). As u grows, the point of maximum xmax approaches 0.
The vertical dashed line is through the point 1/n with n = 30. Right plot: xmax
as a function of u (horizontal dashed line is through 1/n for n = 30).
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Figure 6: Left plot: function g2(x) for β = 1 and α = 30, 50, 75, 100 (from top
to bottom). The vertical dashed line is through the point 1/n with n = 30.
Right plot: xmax as a function of α (horizontal dashed line is through 1/n for
n = 30 intersection the curve at point u∗ ≈ 49.68).
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Figure 7: Left plot: function G3(nδx;α) for β = 1 and α = 50, 100 and 200.
Similarly to the Uniform prior case as α grows, the point of maximum xmax
approaches 0. The vertical dashed line is through the point 1/n with n = 30.
Right plot: xmax as a function of α (horizontal dashed line is through 1/n for
n = 30).
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Figure 8: Left plot: function − log(|nG4(nδx;α)|) for β = 1 and α = 20, 50 and
100. Similar to the Uniform case for G4, as α grows, the point of maximum
xmax approaches 0. The vertical dashed line is through the point 1/n with
n = 30. Right plot: xmax as a function of α (horizontal dashed line is through
1/n for n = 30).
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Figure 9: The optimal doses for different values of λ for the goal function G˜1
when n = 30, c1 = 10
−4 and c2 = 1 (dashed) and for G1 (solid line) as on
Plot (c) in Figure 1.
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Figure 10: Function− log |G˜4(nδx;α)| for the costs c1 = 0.005, c2 = 5 and values
α = 30, 50, 100 (in the order of a decrease). The vertical dashed line is through
the point 1/n with n = 30. The extremal points are xmax = 0.043, 0.028 and
0.015 leading to optimal designs 1/30, 0.028 and 0.015, respectively.
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Figure 11: Solution obtained by medea for p = 0.05, λ1 = 25, and λ2 = 150
shows that the numeric solution is a two atomic measure 18.98 δ0.019 +
11.02 δ0.058 and all the substrate should be used.
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